Jasper Ridge Partners’s Transmedics TMDX Stock Holding History

Jasper Ridge Partners’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-23,915	Closed	-$455K	–	104
2019 Q4	$455K	Buy	+23,915	New	+$439K	0.03%	77

Other funds holding TMDX

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCP

Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jasper Ridge Partners's TMDX Position: Q1 2020 in Review

Jasper Ridge Partners sold out of Transmedics (TMDX) in Q1 2020, closing a stake of 23,915 shares — an estimated $455K sold.

Jasper Ridge Partners first reported a position in TMDX in Q4 2019 and held it in 1 quarter. The position peaked at $455K in Q4 2019. 55 funds tracked by Wall St. Rank hold TMDX as of Q1 2020.

Jasper Ridge Partners reported no remaining Transmedics position as of Q1 2020 after selling out during the quarter.
Jasper Ridge Partners sold 23,915 Transmedics shares in Q1 2020, an estimated $455K.
Jasper Ridge Partners first reported a position in Transmedics in Q4 2019 and held it in 1 quarter.
Jasper Ridge Partners's Transmedics position peaked at $455K in Q4 2019.
55 funds tracked by Wall St. Rank held Transmedics as of Q1 2020.

Based on Jasper Ridge Partners's 13F filing for Q1 2020, filed 13 May 2020.